Search Results - "Brümmendorf, Tim Henrik"
-
1
Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms
Published in International journal of molecular sciences (16-12-2023)“…Myeloproliferative neoplasms (MPN) are rare hematologic disorders characterized by clonal hematopoiesis. Familial clustering is observed in a subset of cases,…”
Get full text
Journal Article -
2
Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer
Published in Clinical cancer research (01-03-2010)“…The HER2 oncogene is involved in the biology of many different tumor types and serves as a prognostic marker and a therapeutic target in breast cancer. In…”
Get full text
Journal Article -
3
Detection of Karyotype Evolution From Peripheral Blood by Sequential FISH Analyses of Circulating CD34+ Cells In MDS Patients: Results of the Ongoing German Multicenter Prospective Diagnostic Study
Published in Blood (19-11-2010)“…Abstract 2937 Chromosomal aberrations in myelodysplastic syndromes (MDS) play a major role in diagnostics, pathogenesis, prognosis, and, more recently, in…”
Get full text
Journal Article -
4
Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation
Published in Journal of neuro-oncology (01-03-2020)“…Purpose Isocitrate dehydrogenase 1 (IDH1) mutations are associated with improved survival in gliomas. Depending on the IDH1 status, TERT promoter mutations…”
Get full text
Journal Article Web Resource -
5
A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy
Published in Haematologica (Roma) (01-07-2015)“…Danusertib is a pan-aurora kinase inhibitor with potent activity against Abl kinase including the gatekeeper T315I mutant. A phase 1 dose escalation study of…”
Get full text
Journal Article -
6
The Fc‐alpha receptor is a new target antigen for immunotherapy of myeloid leukemia
Published in International journal of cancer (01-12-2015)“…Antibody‐based immunotherapy of leukemia requires the targeting of specific antigens on the surface of blasts. The Fc gamma receptor (CD64) has been…”
Get full text
Journal Article -
7
Aging of blood can be tracked by DNA methylation changes at just three CpG sites
Published in Genome biology (03-02-2014)“…BACKGROUND: Human aging is associated with DNA methylation changes at specific sites in the genome. These epigenetic modifications may be used to track donor…”
Get full text
Journal Article -
8
Additional benefits of telomere length (TL) measurements in chronic lymphocytic leukemia
Published in Leukemia & lymphoma (28-01-2019)Get full text
Journal Article